Literature DB >> 16847321

Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells.

Jeanette Nilsson1, Gunnar Bjursell, Marie Kannius-Janson.   

Abstract

The classical mechanism by which prolactin transduces its signal in mammary epithelial cells is by activation of cytosolic signal transducer and activator of transcription 5 (Stat5) via a plasma membrane-associated prolactin receptor-Janus kinase 2 (Jak2) complex. Here we describe an alternative pathway through which prolactin via Jak2 localized in the nucleus activates the transcription factor nuclear factor 1-C2 (NF1-C2). Previous reports have demonstrated a nuclear localization of Jak2, but the physiologic importance of nuclear Jak2 has not been clear. We demonstrate that nuclear Jak2 regulates the amount of active NF1-C2 through tyrosine phosphorylation and proteasomal degradation. Our data also demonstrate a link between prolactin and p53 as well as the milk gene carboxyl ester lipase through nuclear Jak2 and NF1-C2. Hence, we describe a novel pathway through which nuclear Jak2 is subject to regulation by prolactin in mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847321      PMCID: PMC1592781          DOI: 10.1128/MCB.02095-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

Review 1.  Stat transcription factors in mammary gland development and tumorigenesis.

Authors:  C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

Authors:  Daniela Ungureanu; Pipsa Saharinen; Ilkka Junttila; Douglas J Hilton; Olli Silvennoinen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

3.  A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.

Authors:  R Touitou; J Richardson; S Bose; M Nakanishi; J Rivett; M J Allday
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice.

Authors:  G J Lindeman; S Wittlin; H Lada; M J Naylor; M Santamaria; J G Zhang; R Starr; D J Hilton; W S Alexander; C J Ormandy; J Visvader
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

Review 5.  Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway.

Authors:  C J Watson; T G Burdon
Journal:  Rev Reprod       Date:  1996-01

6.  Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells.

Authors:  Jianwu Xie; Matthew J LeBaron; Marja T Nevalainen; Hallgeir Rui
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

Review 7.  Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction.

Authors:  W S Alexander; R Starr; D Metcalf; S E Nicholson; A Farley; A G Elefanty; M Brysha; B T Kile; R Richardson; M Baca; J G Zhang; T A Willson; E M Viney; N S Sprigg; S Rakar; J Corbin; S Mifsud; L DiRago; D Cary; N A Nicola; D J Hilton
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

8.  Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.

Authors:  Marja T Nevalainen; Jianwu Xie; Lukas Bubendorf; Kay-Uwe Wagner; Hallgeir Rui
Journal:  Mol Endocrinol       Date:  2002-05

9.  Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium.

Authors:  Jonathan M Shillingford; Keiko Miyoshi; Gertraud W Robinson; Sandra L Grimm; Jeffrey M Rosen; Hans Neubauer; Klaus Pfeffer; Lothar Hennighausen
Journal:  Mol Endocrinol       Date:  2002-03

10.  Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium.

Authors:  K Miyoshi; J M Shillingford; G H Smith; S L Grimm; K U Wagner; T Oka; J M Rosen; G W Robinson; L Hennighausen
Journal:  J Cell Biol       Date:  2001-11-12       Impact factor: 10.539

View more
  31 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 2.  Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations.

Authors:  Lachlan Harris; Laura A Genovesi; Richard M Gronostajski; Brandon J Wainwright; Michael Piper
Journal:  Dev Dyn       Date:  2014-09-11       Impact factor: 3.780

3.  Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.

Authors:  M Kondyli; G Gatzounis; A Kyritsis; J Varakis; M Assimakopoulou
Journal:  J Neurooncol       Date:  2010-03-25       Impact factor: 4.130

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

5.  HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Yi Liu; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Mol Endocrinol       Date:  2011-08-04

6.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

7.  Nuclear factor one transcription factors in CNS development.

Authors:  Sharon Mason; Michael Piper; Richard M Gronostajski; Linda J Richards
Journal:  Mol Neurobiol       Date:  2008-12-05       Impact factor: 5.590

8.  The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Suzanne M Wetz; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

Review 9.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

10.  Nuclear factor I-A represses expression of the cell adhesion molecule L1.

Authors:  Tanja Schneegans; Uwe Borgmeyer; Moritz Hentschke; Richard M Gronostajski; Melitta Schachner; Thomas Tilling
Journal:  BMC Mol Biol       Date:  2009-12-14       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.